Literature DB >> 2285299

Ampicillin-resistant enterococcal species in an acute-care hospital.

S E Oster1, V A Chirurgi, A A Goldberg, S Aiken, R E McCabe.   

Abstract

A prospective review of all enterococcal isolates for 13 months showed that 9.0% were resistant to ampicillin (MIC, greater than or equal to 16 micrograms/ml; zone diameter, less than 15 mm), as determined by the Vitek system, disk diffusion, microdilution MIC testing, and macrodilution MIC testing. All were beta-lactamase negative. A total of 19 and 3 resistant isolates were from urine and intravascular sites, respectively. Ampicillin-resistant enterococci appear to be a growing clinical problem.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2285299      PMCID: PMC171938          DOI: 10.1128/AAC.34.9.1821

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Species identities of enterococci isolated from clinical specimens.

Authors:  K L Ruoff; L de la Maza; M J Murtagh; J D Spargo; M J Ferraro
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

2.  Comparison of two beta-lactamase-producing strains of Streptococcus faecalis.

Authors:  B E Murray; D A Church; A Wanger; K Zscheck; M E Levison; M J Ingerman; E Abrutyn; B Mederski-Samoraj
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

3.  In vitro studies of plasmid-mediated penicillinase from Streptococcus faecalis suggest a staphylococcal origin.

Authors:  B E Murray; B Mederski-Samoraj; S K Foster; J L Brunton; P Harford
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

4.  One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to benzylpenicillin.

Authors:  R Williamson; C le Bouguénec; L Gutmann; T Horaud
Journal:  J Gen Microbiol       Date:  1985-08

5.  Characterization and comparison of two penicillinase-producing strains of Streptococcus (Enterococcus) faecalis.

Authors:  J E Patterson; B L Masecar; M J Zervos
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

6.  Single-concentration broth microdilution test for detection of high-level aminoglycoside resistance in enterococci.

Authors:  M J Zervos; J E Patterson; S Edberg; C Pierson; C A Kauffman; T S Mikesell; D R Schaberg
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

7.  Susceptibilities of enterococci to twelve antibiotics.

Authors:  R W Tofte; J A Solliday; K B Crossley
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

8.  Transition from resistance to hypersusceptibility to beta-lactam antibiotics associated with loss of a low-affinity penicillin-binding protein in a Streptococcus faecium mutant highly resistant to penicillin.

Authors:  R Fontana; A Grossato; L Rossi; Y R Cheng; G Satta
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

9.  Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility.

Authors:  D Kaye
Journal:  Arch Intern Med       Date:  1982-10-25

10.  Enterococcal infections in patients treated with moxalactam.

Authors:  R C Moellering
Journal:  Rev Infect Dis       Date:  1982 Nov-Dec
View more
  17 in total

1.  Activity of HMR 3647 compared to those of six compounds against 235 strains of Enterococcus faecalis.

Authors:  D B Hoellman; G Lin; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

2.  Activities and time-kill studies of selected penicillins, beta-lactamase inhibitor combinations, and glycopeptides against Enterococcus faecalis.

Authors:  D B Hoellman; M A Visalli; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

3.  Comparison of Enterococcus raffinosus with Enterococcus avium on the basis of penicillin susceptibility, penicillin-binding protein analysis, and high-level aminoglycoside resistance.

Authors:  M L Grayson; G M Eliopoulos; C B Wennersten; K L Ruoff; K Klimm; F L Sapico; A S Bayer; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

4.  Molecular typing of ampicillin-resistant, non-beta-lactamase-producing Enterococcus faecium isolates from diverse geographic areas.

Authors:  S M Donabedian; J W Chow; J M Boyce; R E McCabe; S M Markowitz; P E Coudron; A Kuritza; C L Pierson; M J Zervos
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

5.  Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections.

Authors:  J K James; S M Palmer; D P Levine; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

6.  Species identification and antibiotic susceptibility testing of enterococci isolated from hospitalized patients.

Authors:  J W Gray; D Stewart; S J Pedler
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

7.  In vitro activity of RP 59500, a semisynthetic injectable pristinamycin, against staphylococci, streptococci, and enterococci.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

8.  Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution.

Authors:  M L Grayson; G M Eliopoulos; C B Wennersten; K L Ruoff; P C De Girolami; M J Ferraro; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

9.  Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.

Authors:  M C Ramos; M L Grayson; G M Eliopoulos; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

10.  Ampicillin-resistant Enterococcus raffinosus in an acute-care hospital: case-control study and antimicrobial susceptibilities.

Authors:  V A Chirurgi; S E Oster; A A Goldberg; M J Zervos; R E McCabe
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.